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Abstract
Tumor shape and size eﬀect on drug delivery to solid tumors are studied, based on the application of the governing
equations for ﬂuid ﬂow, i.e., the conservation laws for mass and momentum, to physiological systems containing solid
tumors. The discretized form of the governing equations, with appropriate boundary conditions, is developed for
predeﬁned tumor geometries. The governing equations are solved using a numerical method, the element-based
ﬁnite volume method. Interstitial ﬂuid pressure and velocity are used to show the details of drug delivery in a solid
tumor, under an assumption that drug particles ﬂow with the interstitial ﬂuid. Drug delivery problems have been most
extensively researched in spherical tumors, which have been the simplest to examine with the analytical methods.
With our numerical method, however, more complex shapes of the tumor can be studied. The numerical model of
ﬂuid ﬂow in solid tumors previously introduced by our group is further developed to incorporate and investigate
non-spherical tumors such as prolate and oblate ones. Also the eﬀects of the surface area per unit volume of the
tissue, vascular and interstitial hydraulic conductivity on drug delivery are investigated.
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Introduction
Cancer causes one in every four deaths in North America
and is the secondmost common cause of death worldwide
[1]. Solid tumors account for 85% of human cancers [1].
Although the most important cancer treatment is surgi-
cal removal of such tumors, the key to a successful cure
often involves eﬃcient delivery of anticancer drugs to
the tumor site after the surgery. Many new drugs have
been developed, but lack of an eﬃcient means of deliv-
ery makes them less eﬀective. Moreover, some of these
drugs induce biochemical reactions in the body that pro-
duce toxicity. Bioengineers are primarily concerned with
both the transport of drugs within the body (which usually
involves systemic delivery through the blood supply) and
with biochemical reactions or conversions at tumor sites
[2,3]. All of these problems demonstrate that solutions to
drug delivery limitations are urgently needed [1].
Two factors inhibit the eﬀective delivery of drugs within
tumors: non-uniform blood supply and non-uniform
interstitial pressure distribution [4,5]. Drugs concentrate
most readily in areas with the best blood supply. In solid
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tumors, these areas are closest to the blood vessels (the
vasculature) and a tumor’s peripheral walls; however, 90%
of a tumor receives little or no drug, meaning that treated
tumors tend to regrow, as only their outer cells have been
killed by the drug [6-9]. Variations in the interstitial (i.e.,
of connective tissue in which cells are embedded) pressure
reduce ﬂuid exchange and further inhibit the movement
of the drug into the center of the tumor.
Previous research has shown that drugs administered
systemically are not uniformly reaching tumor sites.
Baxter et al. have shown that, in addition to blood
ﬂow heterogeneities and impeded interstitial transport,
another mechanism eﬀectively contributes to the non-
uniform distribution of drugs: high interstitial pressure
in solid tumors [10-12]. High interstitial pressure limits
drug transport in two ways: 1) it reduces the driving force
that is the result of the interstitial ﬂuid pressure and vas-
cular pressure diﬀerence; 2) it moves ﬂuid to the outer
layers of the tumor in which the interstitial pressure has
its minimum. Both these eﬀects are shown schematically
in Figure 1. The ﬁrst eﬀect decreases the driving force
for transcapillary exchange of ﬂuid and, therefore, drugs.
Low ﬁltration (liquid source per tissue volume) occurs at
the center of the tumor as a result of the high interstitial
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Figure 1 Cross sectional schematic of a solid tumor that shows the three diﬀerent regions of a solid tumor, IFP distribution, drug
concentration and ﬁltration distribution from blood vessels [14], doi:10.1371/journal.pone.0020344.g001.
pressure or low driving force, and high ﬁltration occurs
at the periphery of the tumor as a result of the low inter-
stitial pressure or high driving force. The second eﬀect of
the high interstitial pressure results in a radially outward
convective ﬂux in the interstitium as ﬂuid ﬂows towards
the outer layers of the tumor. This eﬀect is illustrated in
Figure 1 as an outward convection due to interstitial ﬂuid
pressure gradient. The value of the radially outward ﬂuid
velocity at the tumor rim for a solid tumor (mammary
adenocarcinoma s.c.) with a 1 cm radius, 4.2 g , is 0.1 ∼
0.2μm/s [2]. Figure 1 demonstrates another important
feature of drug delivery to tumors: an inward diﬀusion due
to concentration gradient of the drug. Eﬀective penetra-
tion into a solid tumor requires that the velocity of the
diﬀusion process be higher than that of the convection
process [13]. On the other hand, uniformly distributed
high interstitial pressure in the center of a tumor blocks
convection and, consequently, causes the heterogeneous
perfusion of blood into the center of tumors, resulting in
heterogeneous distribution of drugs [12].
Modeling drug delivery involves processes such as drug
diﬀusion, convective transport in extracellular matrices,
drug extravasation from blood vessels, tissue elimination
by the lymphatic system, and intracellular internalization.
In all of these processes, computational ﬂuid dynamics
(CFD) can play a crucial role in clarifying the mechanisms
of drug delivery from the injection site to absorption
by a solid tumor. In-vitro release proﬁles of systemically
administered drugs have been combined with state of the
art computational ﬂuid dynamics simulations to predict
both temporal and spatial drug delivery in many studies
[15-20]. Temporal and spatial changes in blood ﬂow have
also been studied with a focus on capillary-network or
single-vessels [21,22]. Before Baxter et al. [2,23,24] intro-
duced their innovative model of interstitial pressure as a
function of tumor radius, little was known about tumor
modeling, except that interstitial pressure is highest at the
center of a tumor [25] and that pressure is directly propor-
tional to tumor size [25,26]. Themain focus of future drug
delivery modeling involves the transport of the drug in tis-
sues after drug release by either systemic administration
or implantation.
As spherical tumors are the easiest to examine analyt-
ically, they have been used in most studies. The eﬀect
of tumor shape has not been addressed in the literature
except the analytical study of by El-Kareh and Secomb
[27]. The numerical method introduced here allows mod-
eling of more complex shapes and promotes a better
understanding of the complex mechanisms of interstitial
ﬂuid transport that eﬀective drug delivery must depend
on. In studying tumor modeling, the numerical method,
which introduces more features of drug delivery to solid
tumors, is more eﬀective than the analytical method. To
design an optimum scheme for drug delivery, the trans-
port mechanisms and obstacles to drug delivery have to be
clariﬁed, which is one of the main objectives of this paper.
The proposed CFD model is made for both spherical
and non-spherical tumors and their surrounding normal
tissues. This model can be further extended to study
geometries reconstructed from high resolution images.
In this study the tumor and its surrounding tissue are
assumed to be rigid porous media. The vasculature as a
source term varies spatially. The grid generation divides
the whole domain or geometry into ﬁnite volumes, called
meshes. Interstitial ﬂuid ﬂow equations in porous media
are solved using a CFD code (based on the proposed
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CFD model) that employs unstructured grids (tetrahedral
elements) to handle non-spherical tumors.
Methods
The tissues most relevant to this discussion are the vas-
culature (vessels that, with the heart, comprise the cir-
culatory system that carries blood throughout the body),
the interstitium (or interstitial space), and the cells. Also
relevant is the lymphatic system, which, simply put, is
responsible for tissue drainage. The vasculature system
involves vessels (essentially tube-like structures) of vary-
ing sizes, from the large arteries and veins down to the
much smaller arterioles, venules and capillaries [28]. The
interstitium is formed of ﬁbers such as collagen, which
gives structural stability, glycosaminoglycans (GAG), and
other proteins. Together, these ﬁbers make up the gel-like
region between blood vessels and cells. The cells, occu-
pying the cellular space, include speciﬁc tissue cells (i.e.,
the cancer cells of a solid tumor) and others such as per-
icytes, macrophages, and ﬁbroblasts not discussed in this
paper [2,23,24]. In normal physiology, ﬂuid seeps slowly
but constantly fromblood vessels into the surrounding tis-
sues. The lymphatic system then reabsorbs this lost ﬂuid
and returns it to the blood stream. All the above tissues
must be considered in any discussion of drug delivery to
tumors. Speciﬁcally, to be eﬀective, drugs must cross the
blood vessel wall, traverse the interstitial space containing
the cancer cells, and bind to and (if the target is intracel-
lular) penetrate the cancer cell membrane. The lymphatic
system then removes excess ﬂuid and debris. However,
a lack of such lymphatic drainage in solid tumors has
been reported in the literature [2,3]. Computer simula-
tions show that this lack of lymphatic system involvement
may result in a build up of interstitial pressure, leading to
cessation of the usual blood seepage from vessels. Conse-
quently, large molecules cannot be carried out of vessels
to interact with tissue. As some drug particles, including
Monoclonal Antibodies (MAbs) used to ﬁght cancer, are
large and move very slowly within tissues, they cannot
reach the tumor site and are thus ineﬀective [2].
Mathematical Model of Interstitial Fluid Transport
The distribution of vasculature and cells in solid tumors
is spatially heterogeneous. Solid tumors have a center
necrotic core where most of the cells are dead. The outer
boundary of such tumors contains many exchange ves-
sels, a large blood supply, and fast-dividing cells. There-
fore, the mathematical model should be accurate enough
to include the dependency of physiological parameters,
such as the hydraulic conductivity, on space; that is, it
must be able to clearly represent all the physical vari-
ations in a tumor. Nevertheless, because the time scale
of transport phenomena is much less than that of tumor
growth, the physiological parameters can be considered
time independent [2]. In a macroscopic model, only the
distribution of variables, such as interstitial pressure and
concentration, over the length scale of the tumor radius
is important, and microscopic characteristics, such as
blood vessels, cells, and the interstitial matrix, are not
involved directly. Comparison of the tumor radius, on the
order of magnitude of 1cm, O(1cm), with the intercapil-
lary distance (the average distance between two capillar-
ies),O(100μm), indicates that variations overmicroscopic
length scales can be averaged out [29]. The screening
length,
√
μk (in which μ and k are the viscosity of the
interstitial ﬂuid and the hydraulic conductivity of the
interstitium, respectively), is on the order of 60A˚ ; there-
fore, the ﬂuid transport in the tumor interstitium can
be described by Darcy’s law for ﬂow through a porous
medium [3,29-33]:
v = −k∇Pi in general
v = −k ∂Pi










, v [m/s] and r[ cm]
are the hydraulic conductivity of the interstitium, the
interstitial ﬂuid pressure, the interstitial ﬂuid velocity and
the radial position, respectively. In the case of anisotropic
and heterogeneous porous media, k is a tensor and func-
tion of the location in the medium.
The mass balance equation for a steady state incom-
pressible ﬂuid shows that the divergence of the ﬂuid is
zero, or mathematically,
∇ · v = 0 (2)
The same equation is also applicable in porous media
if there is no ﬂuid source or ﬂuid sink in the medium.
However, in most biological tissues, sources and sinks
are present. For instance, between interstitial space and
the blood or lymph vessels, ﬂuid is exchanged; therefore,
the steady state incompressible form of the continuity
equation must be modiﬁed as
∇ · v = φB(r) − φL(r) (3)
where v is the ﬂuid velocity in the representative elemen-
tary volume (REV). The continuity equation can also be
written as
∇ · (vf ) =
⎧⎨
⎩
φB(r) − φL(r) for r ≥ Rn
0 for r < Rn
(4)









the radius of the necrotic core, the porosity or the volume
fraction of ﬂuid, the ﬂuid velocity averaged in the volume
of the ﬂuid phase, the ﬂuid source term, and the lymphatic
drainage term, respectively. In biological tissues, the two
last terms signify the rate of ﬂuid ﬂow per unit volume
from blood vessels into the interstitial space and from
Soltani and Chen Journal of Biological Engineering 2012, 6:4 Page 4 of 15
http://www.jbioleng.org/content/6/4
the interstitial space into lymph vessels, respectively. Both
rates can be evaluated through Starling’s law. It should be
noted that Eq. (4) in this general form is applicable to any
kind of biological tissue, whether normal or cancerous. In
dead tissues, with no ﬂow in the blood or lymph vessels,
the value for both terms is zero. The ﬂuid source term is
governed by Starling’s law as follows [34,35]:
φB(r) = JVV =
LPS
V (PB − Pi − σs(πB − πi)) (5)





metric ﬂow rate out of the vasculature per unit volume of






, the surface area per unit volume for transport










, the vascular pressure;










, the osmotic pressure of the interstitial
ﬂuid. The diﬀerent types of pressure used in Eq. (5) are
shown in Figure 2. It should be noted that the lymphatic
drainage term is proportional to the pressure diﬀerence
between the interstitium and the lymphatics:
φL(r) = JLV = LPLSLV (Pi − PL) for r ≥ Rn
φB(r) = φL(r) = 0 for r < Rn
(6)





















, the hydrostatic pressure of the
lymphatics.
Combination of Darcy’s law and the continuity equation
results in
−∇ · k∇Pi = φB(r) − φL(r) (7)
For a very special case, when k is constant and there are
no sinks and sources (for example, in the necrotic core),
the interstitial pressure can be expressed by the very well-
known Laplace equation.
∇2Pi = 0 (8)
If all parameters except Pi are assumed to be constant,
substituting Eqs. (5) and (6) in Eq. (7) results in




Rearranging Eq. (9) for an arbitrary shape of a solid tumor
results in
∇2Pi = LPS + LPLSLkV (Pi − Pss) (10)




R2 (Pi − Pss) (11)
PSS is deﬁned later by Eq. (15). Using the deﬁnition of
the Laplace operator, Eq. (12), in the spherical coordinate
system, Eq. (11) is written as in Eq. (13).
Figure 2 Capillary microcirculation schematic and diﬀerent types of pressure [14], doi:10.1371/journal.pone.0020344.g002.
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R2 (Pi − Pss) (13)
In Eqs. (11) and (13), the ratio of interstitial resistance
to vascular resistance is introduced in terms of α, the
dimensionless parameter deﬁned by Eq. (14).
α = R√(LPS + LPLSL)/kV (14)
PSS = (LPSPe + LPLSLPL)/(LPS + LPLSL) (15)
The steady state pressure, PSS, is the interstitial pressure
at which the eﬄux from the vasculature and inﬂux into the
lymphatics are equal, and is deﬁned by Eq. (15). Eﬀective
pressure, Pe, in Eq. (15), is a parameter deﬁned by vas-
cular pressure, plasma osmotic pressure, and interstitial
osmotic pressure through Eq. (16).
Pe = PB − σs(πB − πi) (16)
Applying the appropriate boundary conditions and also
all the constants mentioned earlier, the more general form
of the governing equation, Eq. (10), can be used to cal-
culate the interstitial ﬂuid velocity (IFV) and interstitial
ﬂuid pressure (IFP) proﬁles in solid tumors. Of note, for
spherical solid tumors, simpler forms of the governing
equation, Eq. (11) or (13), can be used. Additionally, α is a
dimensionless constant used here for convenience (only in
spherical tumors); in general (arbitrary shapes), more fun-
damental physical constants such as LP, S, LPL, SL, k, and
V , used in Eq. (10), should be used. No lymph vessels in a
solid tumor means SL = 0; thus, Eqs. (10) , (13) and (14)
can be simpliﬁed as follows:











R2 (Pi − Pe) (18)
α = R√(LPS)/kV (19)
in which the interstitial pressure that yields zero net
volume ﬂux out of the vasculature is called the eﬀective
pressure, Pe, Eq. (16). The steady state pressure and eﬀec-
tive pressure in solid tumors with no lymph vessels are the
same. If Pi = Pe, no exchange of ﬂuid occurs between the
interstitial space and blood vessels.
Due to symmetry, there is a no ﬂux boundary condition
at the center of the tumor; i.e.,
∇Pi = 0 or ∂Pi
∂r = 0 for r = 0 (20)
At the outer edge of the solid tumor, (r = R for a spheri-
cal tumor), two types of boundary conditions are possible.
In the ﬁrst type, where the pressure in the surrounding
tissue is ﬁxed, the tumor pressure at the outer edge is the
same as the surrounding pressure, Psur.
Pi = Psur for outer region, r ∈ 
 (21)
This condition is applicable for an isolated tumor
[36,37]. In the second type, the solid tumor is surrounded
by normal tissues. Pressure decreases smoothly over a dis-
tance; therefore, the continuity of pressure and velocity
should be considered as an appropriate boundary con-
















+ indicate the tumor and normal tis-
sue at the outer edge of the solid tumor; kt and kn are the
hydraulic conductivity of the interstitium in tumor and
normal tissues, respectively. It should be noted that, in the
second type, all the equations mentioned for the tumor
tissue have to be solved for the normal tissue as well.
For the normal tissue, far enough from the solid tumor
that the pressure is constant, the ﬁrst type of bound-
ary condition, Eq. (21), must be applied. Figure 3 shows
these two types of boundary conditions. The solution can
now be obtained analytically or numerically to ﬁnd the
IFV and IFP proﬁles for each of the two boundary con-
ditions. In this work, the numerical method has been
used. An element-based ﬁnite volume method (EB-FVM)
is applied to discretize the equations. The EB-FVM com-
bines the capability of the ﬁnite element method (FEM)
for handling complex geometries with the sound physical-
based properties of the ﬁnite volume method (FVM) [38].
The discretized form of the governing equations, in their
general form, is then linearized and solved implicitly.
The Semi Implicit Method for Pressure Linked Equations
(SIMPLE) algorithm is used as the coupling method for
pressure and velocity terms. Finally, the converged form
of the solution is calculated using an iterative method. To
improve the convergence rate, the method of successive
over-relaxation (SOR) is applied, with an under relaxation
factor equal to 0.75. The criterion for the convergence is
to reduce the residual by 6 orders of magnitudes. In order
to check the grid independency of the code, the largest
tumor in this study is chosen and the results for three
diﬀerent grids are compared, indicating the conservative
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Figure 3 Two types of boundary conditions at the outer edge of the tissue [14], doi:10.1371/journal.pone.0020344.g003.
property of the numerical method. The ﬁnal choice of
the grid in this test case includes 11904 control volumes.
For other tumor geometries the same mesh parameters
are applied.
The material properties for tumor and normal tissue
were taken from the simulation studies of Jain and Baxter
[12] and are shown in Table 1. It should be noted that
tissue properties vary greatly among diﬀerent organs, for
both normal and cancerous tissues; therefore, parameters
introduced in Table 1 should be updated for new appli-
cations. As mentioned earlier, tissue transport properties
are often anisotropic and heterogeneous. Geometric and
physiological properties of anisotropic and heterogeneous
Table 1 Material properties used in numerical simulations,
as taken from [12]





Normal 0.36× 10−7 Rippe et al. (1978)





Normal 8.53× 10−9 Swabb et al. (1974)





Normal 70 Pappenheimer et al. (1951)















Normal 10 Wiederhielm (1979)
Tumor 15 Jain (1987a)
σs Normal 0.91 Ballard and perl (1978)
Tumor 0.82 Curry (1984)
tissues aﬀect drug delivery. This issue can be solved with
the help of diﬀusion tensor imaging (DTI). A good appli-
cation of this method in brain tumors is discussed by
Linninger et al. [39].
Results
The actual tumor shape is not necessarily spherical. How
to handle the patient’s speciﬁc tumor and tissue dimen-
sions in transport equations is discussed in the literature
[40]. To study diﬀerent shapes of solid tumors – spher-
ical, oblate (ﬂattened), and prolate (elongated) – shown
in Figure 4, the governing equation is solved numerically
[14]. Generally speaking, it is believed that increasing the
hydraulic conductivity of tumor vessels increases the drug
delivery to tumor cells. Many researchers, such as Sands
et al. [7], Khawli et al. [41], LeBerthon et al. [42], and Cope
et al. [43], have stated the abovementioned hypothesis and
tried to explain their experimental results based on it.
Figure 5 shows the volumetric ﬂow rate out of the vascu-
lature per unit volume, also called liquid source per tissue
volume or ﬁltration ﬂux, at the diﬀerent tumors’ centers
as a function of the multiplication of hydraulic conduc-
tivity of the microvascular wall and surface area per unit
volume, based on Eq. (5), which can be rewritten as Eq.
(24):
φB(r) = JVV =
LPS
V (Pe − Pi) (24)










, the surface area per unit volume















, the interstitial ﬂuid
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Figure 4 Diﬀerent shapes of solid tumors: spherical, oblate, and prolate.
pressure. All parameters used to solve this equation are
listed in Table 1.
Figure 5, shows that in a spherical solid tumor with a
certain radius, R, if hydraulic conductivity is increased,
the volumetric ﬂow rate ﬁrst increases to reach an opti-
mum value (maximum) and then decreases. This graph
also indicates that an increase in the diameter of spheri-
cal solid tumors causes a decrease in the optimum value
of the volumetric ﬂow rate. Decreasing one order of mag-
nitude of tumor radius increases the volumetric ﬂow rate
approximately two orders of magnitude. This optimum
value occurs in response to a small value of hydraulic
conductivity in spherical solid tumors with a relatively
larger diameter. The values of hydraulic conductivity that
result in optimum values of the ﬂux are called optimum
values of hydraulic conductivity. The ﬁltration ﬂux (or the
volumetric ﬂow rate), shown in Figure 5 as a function of
LpS/V , indicates that the usual values for Lp or S/V in
the literature, listed in Table 1, are much greater than the
optimum values shown in this graph. Loptp , the optimum
value of hydraulic conductivity, can be found easily in a
graph such as Figure 5 for diﬀerent tumor sizes, or one can
ﬁnd the appropriate size for a speciﬁc tumor tissue with a
known value of Lp to have the maximum drug ﬂow rate.
In Figure 5, Lp changes linearly from its minimum values
to its maximum values. On the other hand, the pressure
Figure 5 Liquid source (volumetric ﬂow rate out of the vasculature per unit volume of tissue or ﬁltration ﬂux) per tissue volume at the
tumors’ center, as a function ofmultiplication of hydraulic conductivity of the microvascular wall and surface area per unit volume.
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diﬀerence (between eﬀective pressure and IFP) changes
from Pe (when IFP is equal to zero) to zero (when IFP is
equal to the eﬀective pressure). When Lp is at its mini-
mum, the pressure diﬀerence is at its maximum, and vice
versa. This circumstance results in a peak in the volumet-
ric ﬂow rate curve in terms of the hydraulic conductivity
of the microvascular wall, Lp, and surface area per unit
volume, S/V , or a combination of these factors through
Eq. (24).
Baxter et al. [12] stated that, with a decrease in the sur-
face area of the tumor vasculature, the amount of ﬂuid ﬁl-
tered and therefore the amount of drug ﬁltered decreases
as well. However, Figure 6 shows that this statement is
true for just part of the curves. The same behavior occurs
for surface area per unit volume instead of hydraulic con-
ductivity; the graph showing this similarity is shown in
Figure 6.
For most cancerous tissues, the hydraulic conductivity
of the interstitium is not reported accurately in the liter-
ature [27]. For those cases reported in the literature, such
as recent work of Linninger et al. [44] on estimating the
hydraulic conductivity in porous brain tissue, one can use
inverse method and apply numerical method presented
in this study to calculate the hydraulic conductivity and
compare it with the estimated value in [44]. However, the
change in k has been studied here, and the result, shown
in Figure 7, indicates that k and Lp have opposite eﬀects
on ﬁltration ﬂux. Figure 7 shows the behavior of volumet-
ric ﬂow rate as a function of the hydraulic conductivity
of the interstitium at the centers of spherical tumors of
diﬀerent radii. This ﬁgure demonstrates that in smaller
tumors (0.1 cm radius in this case) the maximum value
of the volumetric ﬂow rate occurs in a smaller value of
the hydraulic conductivity of the interstitium, at least two
orders of magnitude less than that of the larger tumor
with a 1 cm-sized radius. In fact, increasing the value of
k, decreases the amount of α. Low amounts of α result in
low values of IFP. Based on Eq. (24), the eﬀect of low IFP
values is an increase in the volumetric ﬂow rate.
Figure 8 shows that in a spherical solid tumor of a
certain diameter, with an increase in α, which is the
dimensionless parameter deﬁned based on Eq. (19), the
volumetric ﬂow rate increases ﬁrst, but after reaching an
optimum value (maximum), it decreases. The interesting
point about this graph is that the optimum values of the
volumetric ﬂow rate for diﬀerent sizes of spherical solid
tumors occur at the same value of α. This ﬁgure demon-
strates that increasing one order of magnitude of tumor
radius decreases the volumetric ﬂow rate approximately
two orders of magnitude at the same value of α2, almost
equal to 6. The simultaneous eﬀect of eﬀective pressure,
Pe, and size is shown in Figure 9. The pattern for dif-
ferent sizes is the same; the more the eﬀective pressure,
the more the volumetric ﬂow rate. As discussed before
[14] and shown in Figure 9, the lower the tumor size, the
lower the IFP, which results in a more volumetric ﬂow
rate.
Real tumors have unusual shapes. To show the eﬀect of
tumor shape and size on Pi distribution and also the ﬁltra-
tion ﬂux for diﬀerent values of Lp and S/V , the study in
[27] has been loosely reworked here but with a diﬀerent
approach in terms of formulation and solution method to
Figure 6 Liquid source per tissue volume at the tumors’ center, as a function of surface area per unit volume.
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Figure 7 Liquid source per tissue volume at tumors’ center, as a function of the hydraulic conductivity of the interstitium.
cover a greater variety of tumor shapes and sizes. As men-
tioned earlier, the general form of the governing equation
has been used in this paper to study non-spherical solid
tumors, shapes not covered in the literature. Figure 10
shows volumetric ﬂow rate behavior at the center of diﬀer-
ent tumor shapes that have the same volume as a spherical
0.1 cm radius tumor, as a function of multiplication of
the hydraulic conductivity of the microvascular wall and
surface area per unit volume. Diﬀerent colors show the
diﬀerent values of λ (or a/b), the ratio of minor to major
axes of both prolate and oblate spheroids. Clearly, when λ
is 1, all three shapes have become spherical. As is shown,
the general pattern for diﬀerent shapes (spherical, prolate,
and oblate solid tumors) is the same. Rapid increase by
the enhancement of hydraulic conductivity or surface area
per unit volume to an optimum value (maximum), and
then the decrease by enhancement of those parameters, is
the main characteristic of Figures 10 to 13. Simultaneous
Figure 8 Liquid source per tissue volume at tumors’ center, as a function of α, a dimensionless parameter.
Soltani and Chen Journal of Biological Engineering 2012, 6:4 Page 10 of 15
http://www.jbioleng.org/content/6/4
Figure 9 Liquid source per tissue volume at tumors’ center, as a function of eﬀective pressure.
eﬀects of shape and size of the tumors on the ﬂux (volu-
metric ﬂow rate) distribution can be explained according
to these four ﬁgures.
As the labels indicate, each ﬁgure is for a speciﬁc
volume, which is the same for all three shapes and is
based on the size of spherical shapes. These ﬁgures show
that although, qualitatively, all three shapes have the
same behavior, quantitatively, spherical and prolate solid
tumors are very much closer to each other in behavior
than they are to that of oblate solid tumors. This state-
ment is truer for small tumors than larger ones and also
for smaller values of λ. As discussed, by increasing the
radius of solid tumors, the order of volumetric ﬂow rate
decreases, as through Figures 10 to 13. On the other
Figure 10 Liquid source per tissue volume at the center of diﬀerent tumor shapes with the same volume as a spherical 0.1 cm radius
tumor, as a function ofmultiplication of hydraulic conductivity of the microvascular wall and surface area per unit volume.
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Figure 11 Liquid source per tissue volume at the center of diﬀerent tumor shapes with the same volume as a spherical 0.25 cm radius
tumor, as a function of multiplication of hydraulic conductivity of the microvascular wall and surface area per unit volume.
hand, when λ approaches one, all three shapes show the
same behavior. Figure 14 shows the interstitial pressure
distribution at the tumor center for diﬀerent values of λ
(or a/b). It should be mentioned that for each curve, the
volume is constant, and Req is the radius of a spherical
tumor with the same volume as both prolate and oblate
tumors. This ﬁgure indicates that, for large tumors, except
for extremely low values of a/b, which occur with very
thin shapes of tumors, the central pressure is independent
of shape. This study also shows that there are two limits
for the central pressure value: for large tumors, Req >
0.25 cm, Pi ≈ Pe (especially for prolate solid tumors), and
Figure 12 Liquid source per tissue volume at the center of diﬀerent tumor shapes with the same volume as a spherical 0.5 cm radius
tumor, as a function of multiplication of hydraulic conductivity of the microvascular wall and surface area per unit volume.
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Figure 13 Liquid source per tissue volume at the center of diﬀerent tumor shapes with the same volume as a spherical 1.0 cm radius
tumor, as a function ofmultiplication of hydraulic conductivity of the microvascular wall and surface area per unit volume.
for small tumors, Req < 0.02 cm, Pi ≈ Psur, no matter
what the shape of the tumor. For sizes between these two
limits, for example Req = 0.1 cm, as shown in Figure 14,
the central pressure is a function of both tumor shape and
size. Thus, for 0.02 cm < Req < 0.25 cm, Psur < Pi < Pe.
Two limiting cases (in which a prolate spheroid
approaches cylindrical geometry and the oblate spheroid
approaches a planar slab) are interesting to study with
more detail. These limiting cases can be achieved by
Figure 14 Pressure distribution at the center of diﬀerent tumor
shapes, as a function of minor to major axes ratio. Req is the radius
of a spherical tumor with the same volume as both prolate and
oblate tumors.
choosing the very low values of λ (0.01 in this case). The
IFP distributions throughout these geometries for Req =
1.0 cm are shown in Figure 15 to specify the eﬀects of size
and shapemore carefully in these cases. This ﬁgure shows
that for non-spherical tumors, everything hinges on the
smallest dimension, and the other dimension is not impor-
tant. When the smallest dimension of the prolate tumor
is close to or in a comparable size to the spherical one,
the pressure distribution is almost the same, as shown in
Figure 15. For the oblate tumor, as the order of the small-
est dimension is very diﬀerent from that of the spherical
one, pressure distribution is totally diﬀerent in Figure 15.
The same ﬁgures as Figure 15 for other sizes of Req can be
shown here. Only the central IFP values for all Req values
are shown in Figure 14 when λ is very small, 0.01.
Discussion
The eﬀect of increasing the hydraulic conductivity of
microvessels, Lp, in terms of drug delivery to solid tumors
is signiﬁcant to this discussion. There are two opposing
phenomena: the total ﬂuid ﬁltration ﬂux for the whole
solid tumor and local ﬁltration within the solid tumor;
therefore, the liquid source term, the ﬁltration ﬂux at the
center of the tumor, has its highest value for an optimum
value of Lp, as shown by El-Kareh and Secomb [27]. As
they have shown in their study analytically, and is indi-
cated here numerically, this optimum value of Lp is a
function of the size and shape of solid tumors. An increase
in Lp has a direct eﬀect on the total rate and an opposite
eﬀect on the local ﬁltration ﬂux. Increased vessel leakiness
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Figure 15 Pressure distribution of diﬀerent tumor shapes with the same volume as a spherical 1.0 cm radius tumor, as a function of
dimensionless length.
cannot result in more uniform drug distribution through
tumors much larger than 0.25 cm.
Starling’s law shows that, because of low diﬀusivity, the
dominant form of drug transport through vessel walls
(transvascular transport) is convection [27]. Based on
Eq. (5), both hydraulic conductivity of the vessel wall
and pressure diﬀerence across the wall are eﬀective in
convective transport, again according to Starling’s law.
Similar behavior is true for S/V ; thus, an increase in Lp
and S/V does not have a positive eﬀect, and there are opti-
mum values for both of these parameters. However, the
analysis of the work done in [27], as well as this study,
shows that, except when the nodule radius is smaller than
0.1 cm, the advantage of decreasing Pi is more important
than that of decreasing the surface area.
As indicated, an increase in the hydraulic conductivity
results in a volumetric ﬂow increase, but after a continued
increase, volumetric ﬂow approaches a certain value for
all diﬀerent tumors. This pattern for tumors of all diam-
eters is the same; the only diﬀerence is that the smaller
the tumor diameter, the sooner the leveling in volumetric
ﬂow.
The parameter α does not apply exactly in a non-
spherical tumor; therefore, the general form of the gov-
erning equation, diﬀerent from the more speciﬁc form of
that applied in spherical solid tumors, has to be used here.
This parameter, α, is a combination of other fundamental
variables such as hydraulic conductivity, which turns out
to have a clean short deﬁnition when solved for a sphere.
This study shows that for a distinctly non-spherical tumor
(such as a prolate or oblate), everything hinges on the
shortest dimension, and the longer dimension is irrele-
vant, as any ﬂuid or material ﬂows to reach the closest
surface.
Because El-Kareh et al. [27] used an analytical approach
to solve the governing equations in prolate and oblate
spheroidal shapes, they had to change the coordinate
system from a spherical one to a more complicated coor-
dinate system, with oblate and prolate spheroidal coordi-
nates. In this coordinate system, the governing equation,
the Helmholtz equation, has a much more complicated
form than the original equation. The solution for this
new form of equation is a Fourier series. In the work
proposed here, the numerical method is applied and, obvi-
ously the solution is not limited to any speciﬁc shape,
oﬀering a freedom that is one of the main advantages of
the numerical method over the previous one.
Conclusions
The parameter α/R is independent of tumor geometry.
It is a function of hydraulic conductivity (an intersti-
tial property) and vessel permeability. The main problem
is deﬁning a characteristic length instead of R in non-
spherical tumors. The pressure proﬁle, however, is a func-
tion of tumor geometry. Using a solution for IFP that was
calculated assuming a spherical proﬁle will give a solution
as a function of α, r, and R. Not surprisingly, equations
tailored to the diﬀerent tumor shapes will yield diﬀerent
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IFPs, as these pressures are the outcomes of the equations,
and thus reﬂect the discrepancies. What will happen,
whether a tumor is a sphere or not, is that IFP will be
approximately equal to the vascular pressure,PB, through-
out most of the interior. Only near the boundary, whether
that boundary is for a sphere or spheroid, will there be
a steep pressure gradient as IFP falls to the pressure of
the surrounding tissue. For a very small radius, the diﬀer-
ences will be signiﬁcant. Above the critical radius, shape
is almost irrelevant.
This study shows that, as a rule, it is not true that
the leakier the vessels, the higher the value of convective
transport of drugs to solid tumors. The results do show
that only in spherical solid tumors with a radius of less
than 0.25cm, or in spheroidal ones with the same vol-
ume, can drug convection be increased by making vessels
more leaky. For spheroidal shapes, the convection of drugs
inside is higher than it is in spherical ones, and it seems
that for more irregular shapes, which are generally found
in the body due to limitations imposed by neighboring
tissues and organs such as the brain, this eﬀect is more
marked.
For shapes studied in this paper, results show that the
dependency of the maximized ﬂux (as a function of Lp
and S/V or their multiplication) on size is much stronger
than its dependency on shape. It should bementioned that
due to very low diﬀusivity, the high permeability of vessels
cannot support homogeneous distribution inside tumors
because this high value results in more diﬀusive transport
only in a narrow area around the vessels.
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